NxStage Medical, Inc. 4
4 · NxStage Medical, Inc. · Filed Jun 12, 2013
Insider Transaction Report
Form 4
Shea Thomas
SVP Manufacturing Operations
Transactions
- Sale
Common Stock
2013-06-10$13.73/sh−5,000$68,629→ 15,071 total
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2012.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.58 to $13.84. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.